Requirements for safety and quality of intravenous immunoglobulin G preparations.
Open Access
- 1 November 1994
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 57 (Suppl) , 2-5
- https://doi.org/10.1136/jnnp.57.suppl.2
Abstract
The increasing use of intravenous immunoglobulin-G preparations (IVIg) calls for evaluation of the requirements for quality and freedom from infection. The WHO Requirements dating from 1982 have been surpassed by the majority of IVIg preparations. Three methods are used for ensuring safety from infection: the restrictive choice of donor, the precise introductory screening of every individual blood or plasma donation, and the additional active virus inactivation procedures that surpass the virus elimination of, for example, the Cohn-fractionation method. Although it is highly improbable that IVIg can transfer infections, this possibility cannot be completely ruled out even when all the GMP (good manufacturing practice) rules are observed most carefully. Increased safety from infection would be provided if blood and plasma donations were obtained nationally from unpaid voluntary donors and if an additional active viral inactivation procedure was introduced.Keywords
This publication has 5 references indexed in Scilit:
- Clinical Uses of Intravenous ImmunoglobulinsAnnals of Internal Medicine, 1990
- Effect of Ethanol on VirusesPublished by S. Karger AG ,1988
- Clinical uses of intravenous immunoglobulins.1988
- The development of virus-free labile blood derivatives ? A reviewEuropean Journal of Epidemiology, 1987
- Preparation and Properties of Serum and Plasma Proteins. IV. A System for the Separation into Fractions of the Protein and Lipoprotein Components of Biological Tissues and Fluids1a,b,c,dJournal of the American Chemical Society, 1946